ARCA Biopharma Inc (NASDAQ:ABIO)
| 1.56 Real-Time Quote |  +0.03 / +1.96%Today’s Change | 1.13 Today|||52-Week Range 3.58 | -7.14% Year-to-Date |
Latest ABIO News | Press Releases
No recent news for ARCA Biopharma Inc.
Today’s Trading
| Previous close | 1.53 |
| Today’s open | n.a. |
| Day’s range | -- - -- |
| Volume | 2,250 |
| Average volume (3 months) | 904,923 |
| Market cap | $38.4M |
| Dividend yield | -- |
Data as of 04/15/2014
Growth & Valuation
| Earnings growth (last year) | +46.39% |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | +30.00% |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 1.84 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| CTRVContraVir Pharmaceut... | 0.00 | 0.00% |
| ECTEEcho Therapeutics In... | 0.00 | 0.00% |
| SKBISkystar Bio-Pharmace... | 0.00 | 0.00% |
| ENZNEnzon Pharmaceutical... | +0.01 | +1.31% |
Data as of 9:35am ET, 04/16/2014
Financials
| Last reporting date | -- |
| EPS forecast (this quarter) | -- |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$6.9M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Biotechnology |
President, Chief Executive Officer & Director Michael R. Bristow |
Chief Financial Officer Patrick M. Wheeler |
Corporate headquarters Westminster, Colorado |
Forecasts
